Definium Therapeutics, Inc. (DFTX) — Financial Flexibility Index
Definium Therapeutics, Inc. (DFTX) has a Financial Flexibility Index of -0.39x as of December 2025. Free cash flow of $-41.89 Million (operating CF $-41.89 Million minus capex $0.00) represents 0% of total liabilities ($107.77 Million). Also explore Definium Therapeutics, Inc. (DFTX) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Definium Therapeutics, Inc. Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Definium Therapeutics, Inc. across 11 annual periods. Check asset allocation strategy of Definium Therapeutics, Inc. to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Definium Therapeutics, Inc. (2015–2025)
Year-by-year free cash flow to debt coverage for Definium Therapeutics, Inc.. For the full company profile including market capitalisation, see DFTX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.22x | $-131.56 Million | $-131.56 Million | $107.77 Million | ▲ +6.4% |
| 2024 | -1.30x | $-79.13 Million | $-79.13 Million | $60.70 Million | ▲ +6.0% |
| 2023 | -1.39x | $-64.36 Million | $-64.36 Million | $46.41 Million | ▲ +47.2% |
| 2022 | -2.63x | $-50.14 Million | $-50.14 Million | $19.08 Million | ▲ +29.2% |
| 2021 | -3.71x | $-45.82 Million | $-45.82 Million | $12.34 Million | ▲ +11.1% |
| 2020 | -4.18x | $-23.60 Million | $-23.60 Million | $5.65 Million | ▼ -888.7% |
| 2019 | 0.53x | $105.34K | $-208.12K | $198.96K | ▼ -98.6% |
| 2018 | 39.05x | $321.39K | $-722.45K | $8.23K | ▲ +111.8% |
| 2017 | 18.44x | $1.48 Million | $-665.98K | $80.44K | ▲ +40104.7% |
| 2016 | 0.05x | $3.46K | $-26.64K | $75.47K | ▲ +100.7% |
| 2015 | -6.22x | $-46.56K | $-46.56K | $7.49K | — |